Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease.
about
Recent insights in the pathogenesis of post-transplantation lymphoproliferative disordersHerpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human DiseaseAP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytesThe Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.Epstein-Barr virus genetics: talking about the BAC generation.Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt's lymphoma exosomes.A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.Inhibition of Epstein-Barr virus lytic cycle by an ethyl acetate subfraction separated from Polygonum cuspidatum root and its major component, emodin.EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.Monitoring of Epstein-Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab.EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies.The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.Antiviral Drugs for EBV.A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
P2860
Q28075701-522E2B4F-550B-451D-9664-C00E26BEDF6DQ31152067-C3A170EC-B806-4902-A9F4-2903E7BEB308Q33640163-F2DA5A1F-1ED9-40D2-B37E-52D42851DE2BQ34457976-11CA22D2-3099-4433-ABC5-6D1EA972A3ACQ34650591-23AE0B14-5EE3-47F6-B252-E29D36194F79Q34720273-FE1793D8-C379-44A6-8051-0AD9C92849B0Q35077651-D28A4612-045A-434F-BE21-1627C4238A5AQ35875632-8B530450-8C3F-4351-9467-1DD1D7F18AD1Q36171933-BDF91CE4-288F-47E1-AF2F-5E5D700682FBQ36205880-DD97D1AC-9B94-4763-9CCF-FB14C4BC5F61Q36498181-B5E6FC61-9069-45F1-9A4D-76AF510A7F7FQ36537637-134A9C0C-4431-4F6C-BE6F-9F0BE17F006AQ37856451-EE96EEE9-ECD0-468D-843D-6CF72E9C0516Q38321333-D3E576CD-74C5-4BBB-891C-AFDA70852ACCQ38849339-41600A5B-05E5-4333-B2C2-3D51A6BF3821Q38907078-74B942E7-ACC2-40CB-9C44-DEEC81D097E2Q38965273-1F0F8E81-5825-4AC3-BB69-0866AB01F6D3Q39032271-550EBB9D-E96B-41B1-901D-D39F7AA0CA5DQ39411850-8C1BC556-3AD1-4253-9FFE-A148461A8FD6Q40696036-7A63ACF7-1D54-4849-9AC7-18F9768699F6Q40760159-4DD76CE0-A380-4E71-9D2F-139F97E731C3Q54221806-A8F31566-9C4E-4972-8322-B1D3E5FE54F1Q54245037-FF6D4635-85A5-4160-A594-C0D991AF92CCQ55461330-EE286A23-18EA-42DA-8B26-B7050CC1038DQ56355742-7B943870-C1B4-4B74-B489-CC880991E2F4
P2860
Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Roles of lytic viral infection ...... d lymphoproliferative disease.
@en
type
label
Roles of lytic viral infection ...... d lymphoproliferative disease.
@en
prefLabel
Roles of lytic viral infection ...... d lymphoproliferative disease.
@en
P2093
P356
P1476
Roles of lytic viral infection ...... d lymphoproliferative disease.
@en
P2093
Elizabeth Barlow
Richard J Jones
Sarah Dickerson
Shannon C Kenney
Wen-Hei Feng
William T Seaman
P2860
P304
P356
10.1002/IJC.22839
P577
2007-09-01T00:00:00Z